Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05051306
Other study ID # 202011HM005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 18, 2021
Est. completion date December 31, 2021

Study information

Verified date March 2022
Source National Taiwan Normal University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Healthy young adults will complete three trials in a randomized crossover counter-balanced order, including two different loads of resistance exercise and sedentary control. During each trial, blood samples will be collected. The investigators hypothesized that high-load and low-load resistance exercise exert similar metabolic responses.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date December 31, 2021
Est. primary completion date March 7, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 20 Years to 30 Years
Eligibility Inclusion Criteria: - Age: 20-30 - Healthy male - Without experience of resistance training Exclusion Criteria: - No acute or chronic musculoskeletal symptoms - Smoking - Alcohol or drug abuse - Fail to conduct resistance exercise

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High-load resistance exercise
Subjects in high-load trial performed 4 sets per exercise, 8 repetitions with load of 85%-8RM with 90 sec of rest between sets.
Low-load resistance exercise
Subjects in low-load trial performed 4 sets per exercise, 15 repetitions with load of 45%-8RM with 90 sec of rest between sets.

Locations

Country Name City State
Taiwan National Taiwan Normal University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan Normal University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in glucose glucose in mg/dL 4-hour during each study intervention
Primary Changes in insulin insulin in mU/L 4-hour during each study intervention
Primary Changes in TG TG mg/dL 4-hour during each study intervention
Primary Changes in uric acid uric acid mg/dL. 4-hour during each study intervention
Secondary Changes in biomarkers of inflammation Biomarkers of inflammation will be measured such as IL-10 in pg/mL and IL-6 in pg/mL. 4-hour during each study intervention
Secondary Changes in cortisol cortisol in ng/mL 4-hour during each study intervention
Secondary Changes in lactate lactate in mmol/L 4-hour during each study intervention
Secondary Changes in complete blood count blood cell count in count per µL 4-hour during each study intervention
Secondary Borgs Ratings of Perceived Exertion (RPE) Borgs RPE is a method of estimating exertion rating, based on a 6 to 20 rating scale (6 being the no exertion at all, 20 being maximal exertion). 1-hour during each exercise intervention
Secondary Changes in ET-1 ET-1 in pg/mL 4-hour during each study intervention
Secondary Changes in NO NO in µmol/L 4-hour during each study intervention
Secondary Changes in biomarkers of muscle damage Biomarkers of muscle damage will be measured such as CK in U/L and LDH in U/L. 4-hour during each study intervention
Secondary Heart rate (HR) HR will be measured during each study intervention. 6-hour during each study intervention
Secondary Visual Analogue Scale (VAS) of appetite Hunger, fullness, desire to eat, and prospective food consumption will be measured via VAS ratings, based on a 100 mm long scale (0 being "not at all", 100 being "extremely"). 6-hour during each study intervention
Secondary Changes in biomarkers of appetite Biomarkers of appetite will be measured such as ghrelin in pg/mL and PYY in pg/mL. 4-hour during each study intervention
See also
  Status Clinical Trial Phase
Completed NCT04496154 - Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood N/A
Not yet recruiting NCT06434701 - Severe COVID-19 Infection in Children Presenting to EDs in Israel and England N/A
Enrolling by invitation NCT05020210 - Effect of Early Treatment With Sivelestat Sodium in ARDS Patients
Completed NCT04084301 - Impact of Cardiopulmonary Bypass Flow on Renal Oxygenation, Blood Flow and Tubular Injury N/A
Completed NCT04597983 - Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists N/A
Not yet recruiting NCT06016023 - Evaluation of Macrophage Inflammatory Protein-1α as a Periodontal Disease Biomarker
Not yet recruiting NCT05990933 - Role of Adrenaline in in the Inflammatory Response in Diabetes N/A
Not yet recruiting NCT04608643 - Inflammatory Markers and Cbc Indices in Severely Malnourished Children
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Recruiting NCT01417923 - The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Phase 4
Terminated NCT01377441 - Effect of Intravenous Ibuprofen on Inflammatory Responses in Patients Undergoing Surgery With General Anesthesia. Phase 4
Completed NCT01301079 - Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia Phase 3
Terminated NCT00578578 - Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels Phase 4
Recruiting NCT04611334 - The Effects of HRV Biofeedback on Chronic Kidney Disease Patient. N/A
Recruiting NCT03510702 - SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
Completed NCT03445234 - Blueberries, Bananas, Exercise Recovery N/A
Not yet recruiting NCT06450704 - Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders N/A
Not yet recruiting NCT05754294 - Electric Polarization of Red Blood Cells : A Cohort Study to Assess the Erythrocytes Membrane Integrity Through Charge Conservation, Following Cardiac Surgery.
Completed NCT04864600 - CANDLE - A Study of Acute Health Effects of Exposure to Particles Generated by Candles N/A
Not yet recruiting NCT04386525 - Omega 3 and Ischemic Stroke; Fish Oil as an Option Phase 4